Andrew Craig Miller - Feb 9, 2024 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
President of R&D
Signature
/s/ Mia Kelley, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
Feb 9, 2024
Transactions value $
-$320,629
Form type
4
Date filed
2/12/2024, 05:11 PM
Previous filing
Apr 20, 2023
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Tax liability -$321K -1.01K -4.14% $317.14 23.4K Feb 9, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting of restricted stock units previously granted to the Reporting Person on February 9, 2023.

Remarks:

Exhibit 24 - Power of Attorney